Plant Impact Share Discussion Threads

[fctwente] 09/10/2014 10:20

here and there, good luck with your investments. As you say I am one who has been stuck on a loss for a long time too. Now there is too much doubting for me to be brave more longer! The profit that is round the corner is still round the corner.

[wan] 09/10/2014 10:19

Fctwente...Your rationale does not stand up if we consider how Bayer has adopted Veritas i.e. in your scenario they did not need to sign a multi-year commercial agreement, unless of course their opinion is materially different to yours!

[fctwente] 09/10/2014 10:15

In my consideration the patent as it fails at EPO will absolutely fail too in other offices. This is a certain process from my knowledge of pharmaceutical.
My thought is that Bayer will select the economic route - this may not be by partnership with PI. If you read the documents it is in my opinion impossible to understand any confidence for the outcome for PI. If Veritas is effective as it definitely appears there will be many rushing to the market for competition. Tere will be also many watching an eye on the situation !!

[wan] 09/10/2014 09:57

fctwente...I had noted your previous comments on such and investigated accordingly. I also noted the following comment in the Commercial Agreeemnt announcement;
"The parties have agreed to an initial, multi-year sales and production forecast and to various commercial and intellectual property responsibilities under the agreement."


So, it is a multi-year agreement, which on the one hand suggests you are wrong about and in particular there only being a small amount of time. That aside and from memory we were told at the Investors Day that Veritas has patent protection in Brazil, so it is likely that the multi-year aspect is attached to Brazil. It is interesting that intellectual property responsibilities got a mention, so perhaps you are right to some degree, in that the IP responsibilities/outcome may lead to a much wider agreement for Veritas.

Perhaps we need to consider if it's possible that (as part of the agreement) Bayer are now responsible (or least assisting), hence your suggestion of PI waiting to the last moment. And maybe PI have an ace up their sleeve with regard to requesting an oral examination, they certainly appeared confident at the Investors Day.

[here and there] 09/10/2014 09:25

I could see Bayer taking part in a fund raising if the monies were to help speed up development of new products. PIM does have a few more in the pipeline at various stages of development.

Apart from that they may well just buy the company outright though I hope they do not for a couple of years. The sales growth of Veritas should be very large over the next two seasons. I would also expect to see agreements for Argentina and the USA, the two other massive Soya growing countries. And this is just one product.

This spike was a great opportunity to top slice or get out for retail investors, many have been stuck on a loss here for years.

Not long till this company will be valued on multiples of profit and expected profit. Company on the cusp atm. Been here 5/6 years, happy to hang for a couple more.

Management are top class and have done exactly what they promised to do

[fctwente] 09/10/2014 09:03

Bayer may well consider a stake but my idea is that it will only be possible if a patent is given. The current situation, apart from what others may say is not at all certain. I have read carefully the documents on the EPO portal and it is clear that very good objections are in place. The latest documents show that Plant Impact have not submit the requested arguments but instead wait until the latest moment and ask for oral examination to explain the same objections. This gives them only a small time more. If of important interest you may read the 11 page document of objections. I have taken this opportunity to also sell my shares but wish all extra good luck. Without patent cover Bayer will have no needs for arrangement.

[wan] 09/10/2014 08:22

Obviously PI ultimately need to make sales, but I would prefer them not to be bullied into commercial agreements by large corporates, especially if they know they have a product that works. We may indeed witness a commercial agreement with Bayer, where both companies actually benefit, which would be somewhat rare in my experience, especially where a very large corporate is concerned. The way Bayer has adopted Veritas does indeed bode well in this regard, and given that they (Bayer) are obviously impressed by the science behind Veritas, I would not be surprised to see Bayer take a stake in PI.

[horace_h] 09/10/2014 08:17

Yes - very interesting fortnight and I'm sure many of us have wondered if some sort of rumour has wandered around and/or whether the share price is starting to reflect potential being realised (at last!).

Good luck with your move to AAU - probably higher risk and reward with that industry sector - but great if it works. In 2009, as I may have said before, I made a good profit selling Chariot Oil shares when they moved from 18.5 to 22p. Six months later they were worth £3 each...

Thanks for the Bayer links, Wan, they add to my patience with this.

[bigglesbingham] 09/10/2014 08:07

I sold 40 k in last two days but held 400000. I wanted to move more into AAU who's forestry permit is due any day and once they get that they have full funding to build mine and become a producer rather than explorer. Still think pim has exceptional management albeit a bit arrogant when selling to the larger companies. I don't mind that and neither did Bayer, but others have.

[wan] 09/10/2014 07:56

I was expecting some profit taking, not that I took part.

It will be interesting to eventually find out what was driving the share price on no new news though.

[wan] 08/10/2014 07:47

More from Bayers ambitions and investments -

10th October 2014 China Daily

Bayer hopes to cure what ails Chinese farms

Bayer CropScience AG, the agricultural subgroup of Germany's Bayer AG, will introduce 21 new products into China before 2020, as well as invest 10 million euros ($12.62 million) in recruiting workers for further expansion, said its global head.

Liam Condon, chief executive officer of Bayer CropScience, said products such as high-yielding seeds, herbicides, fungicides and advanced farming applications will be key drivers of China's agricultural development.

"These new products will be used in the areas of crop protection, non-agricultural pest control, seed treatment and plant biotechnology," said Condon. "We are convinced of the long-term growth potential of agricultural markets despite the increasing volatility of the global market."

To feed a population of more than 1.3 billion, more agricultural and related products are made and sold in China than anywhere else, and overall food consumption has risen over the past decade. China has become a fast-growing market for international agricultural marketers and producers from Europe and the United States.

Full story -

[wan] 06/10/2014 07:44

I have added a Bayer website to the header, aside from the obvious connection, it provides a number of very interesting reads. Bayer Cropscience main website (home) can also be accessed from the same link.

[q1w2e3r4t5] 30/9/2014 10:25

A company with a great pipeline of products including;

(a) second and third stage soya products based on nitrogen rather than calcium and these are being focused on ease of in-field use as well as efficacy
(b) broadening out the use of Veritas to the whole of Brazil (now labelled with Bayer)
(c) considering globalisation of Veritas given that Brazil is only 30% of global soya production (Bayer also in Argentina and US soya)
(d) first stage wheat products
(e) abiotic stress products - which were the ones that got the present management really excited about this whole project in the first place.

And, likely to be cash generative from now on!

DYOR!!!

[roper] 30/9/2014 08:13

Looking good for another leg up this morning....only 1500 on offer at 31p electronically. Bid as you like

[wan] 30/9/2014 08:11

Soybean planting in Brazil appears to be off to a good start -

September 29, 2014

2014/15 Soybean Planting off to a Fast Start in Brazil

The weather has generally been favorable for early soybean planting in Brazil. As of September 26th

Even the Brazilian Minister of Agriculture Neri Geller, who is from Mato Grosso, commented recently that he cannot remember in his 30 years of farming such good early moisture for soybean planting in the state.

Full story -

[horace_h] 26/9/2014 19:17

Good for you. I'm sitting on 50% and similarly happy to await developments and further RNS. After all, even fctwente said something positive about the shares...

Either some more good news is around the corner or the market makers have accepted that the institutional investors and long term retail investors with sizable holdings just wouldn't sell.

But, as always, the market will do what it does.

[miss womble] 26/9/2014 18:50

Despite the share price has been rising through the recent turmoil, I think that this is still a buy. At least I am not taking a 120% profit just yet. Happy farming MW

[fctwente] 26/9/2014 13:55

Miss Womble, my guess is that everybody is busy buying more of this stock !

[miss womble] 25/9/2014 16:43

Where is everybody? MW

[wan] 19/9/2014 07:42

Most will have seen that Bayer intend to spin off their materials division and focus on life sciences, which includes cropscience. The following shows some of the reasons why cropscience will remain a key focus -

Monheim, September 17, 2014 – Bayer CropScience is optimistic about the development perspectives of the agricultural markets and commits to invest significantly to deliver new solutions for sustainable agriculture. “We are convinced of the long-term growth potential of the agricultural markets despite increasing volatility,” said Bayer CropScience CEO Liam Condon at the company’s annual press conference in Monheim, Germany. “We expect the worldwide market for agricultural inputs of crop protection products, seeds and traits to grow to around EUR 100 billion by 2020, up from EUR 50 billion in 2008”, Condon forecasts. Intensification and professionalization of agriculture are among the key drivers for mid- to longterm market development, Condon explained, citing a growing need for sustainable farming solutions. “As Bayer CropScience, we see our role as a key contributor to enable sustainable growth of the farming sector that benefits both growers and society alike,” Condon said. He stressed: “Helping growers produce high-quality, safe and healthy food for everybody around the world, and thereby contributing to a better life for all is our mission.”
EUR 2.4 billion capital expenditure program (2013 – 2016) underway

“In light of the strong demand for our products we are expanding our facilities and our investments in research and development (R&D),” continued the Bayer CropScience CEO. The company has embarked on an investment program in 2013 that will see capital expenditures of EUR 2.4 billion EUR through 2016: Out of this, EUR 1.3 billion will be spent in Europe, with EUR 800 million being planned for Germany alone. Between 2013 and 2016 Bayer CropScience is also planning capital expenditures of some EUR 700 million in North America and approximately EUR 400 million in Latin America and Asia Pacific. The largest individual investments are planned for the Dormagen, Frankfurt and Knapsack sites in Germany, as well as Mobile and Kansas City in the US.

Annual R&D expenses of around EUR 1 billion

Farmers’ demand for the company’s innovative line of products including chemical and biological crop protection products as well as as high-yielding seeds is driving Bayer CropScience to invest further into its R&D capabilities. Over the next few years, Bayer CropScience will invest around EUR 1 billion in R&D annually, helping to fuel the company’s well-filled product pipeline.

Condon stressed the need for agricultural innovation: “Farmers constantly experience new challenges – threats to food security worldwide. Examples here are the devastating citrus greening in orange plantations in the US, dramatically reducing orange supplies, worsening soil salinity in some rice growing areas in South Asia or the growing global productivity gap in wheat.” Condon highlighted efforts at Bayer CropScience to help save orange trees through an integrated approach controlling the citrus greening vector and other harmful pests through novel chemical and biological solutions. Bayer CropScience is also looking to market a rice variety that is twice as tolerant to salinity as currently available varieties, which is scheduled for market launch in India in 2016, followed by Bangladesh and Vietnam.

Another focus is the research and development of improved wheat varieties. Bayer CropScience is already market leader in crop protection products for the world’s most important crop, and started to build up a wheat seeds business in 2010 by entering into a collaboration with the leading Australian research institute CSIRO. “We have mapped out a comprehensive 10 year plan to invest EUR 1.5 billion in the research and development of new solutions for wheat through 2020 – encompassing both seeds and crop protection products,” said Condon. “Seven wheat breeding stations across the crop’s main growing areas around the world are now operating, and the first seeds are to be sold next year in Eastern Europe. Hybrid seed varieties with improved yield are expected after 2020 – an example for the long-term nature of our business,” said Condon.

Full release -

[fctwente] 12/9/2014 08:36

For me I think the sales of 2.5m Sterling is not still enough. Another .7m sterling adding to losses. Until 4m we continue loss making? Soon enough though we will hear of the patent applications. If we have no absolute protection for Veritas then the future sales are to be threatened for sure from competition. For these reasons I think the market has factored previously. Hoping for good news before more increased share price.

[horace_h] 11/9/2014 08:10

I entirely agree Wan - very pleasing, although I'd have loved to finally see an actual profit, primarily for psychological reasons! I happily accept John Brubaker's comment on the planned expenditure - the Brazilian team are more than justifying their formation.

This statement underpins the excellent progress for medium and long term prosperity and, for me, there's no evidence of the need for another cash call. As discussed, I don't see it being needed except to finance the sales drive into wheat - and we've seen how that worked with Soya Beans and Veritas.

As always, the market will give its verdict and the market makers play their games...

[wan] 11/9/2014 07:38

A very good trading update (which perhaps also alleviates the doubters regarding cash requirements). With last years Brazilian sales being a pilot, it's quite clear that there is even better to come in the current financial year. Plus, the Brazilian Soybean season is only just getting started (see post 350 above) i.e. post year end, helping the forecast of cash balances as trending upwards. Not to mention that the management anticipates a greater contribution to overall growth from the UK/Europe and Middle regions in the current financial year.

With the potential to enter new markets (e.g. US and Argentina), there is a a huge amount left to play for!